Strategic Investor Radio

Listen to Rob, CEO, and previous CEO multiple times plus corporate board member for several companies in the industry, discuss this niche in the pharma world.  A publicly traded company, focusing on the delivery system of medications, w/systems offering less toxicology and fewer side effects. W/a proprietary system they offer a delivery system that is unique and is not processed thru the stomach.  Many investors should find this interview and company to be very interesting.